Read the 2024 Annual report Dear Colleagues, As we enter another important year for the European Brain Council (EBC), we are delighted to take a moment to reflect and celebrate the accomplishments of 2024 through our Annual Report. As EBC’s mandate continues to grow and expand across the national, European [...]
On March 11, the European Commission presented the much-anticipated Critical Medicines Act, a proposal aimed at strengthening the resilience and autonomy of the EU’s pharmaceutical supply chain. The European Brain Council (EBC) welcomes this initiative as an important step toward a stronger, more innovative, and competitive Health Union, particularly in light of increased geopolitical [...]
The momentum for national brain strategies is stronger than ever. On 18 March 2025, the European Brain Council (EBC) held its annual Brain Awareness Week event, titled “Brain Health Plans Summit: Towards the Establishment of National Brain Plans in Europe and Beyond”. Hosted by MEP Aurelijus Veryga (ECR, LT), Deputy Coordinator of the European [...]
On February 28, marking the 2025 Rare Disease Day, the European Parliament’s Public Health Committee (SANT) kicked off its survey on rare diseases. The purpose of this public consultation is to provide a basis for the forthcoming work of the Committee in bringing a better understanding of the challenges of persons affected by rare diseases and views of [...]
EBC is thrilled to launch the Research Paper resulting from the second phase of the Rethinking Schizophrenia project, which focused on optimising the care pathway. This report, a collaborative effort from the European Brain Council (EBC) and the European Psychiatric Association (EPA), builds directly on the previous 'Beyond the Voices' Policy Report released in [...]
The European Brain Council (EBC), in collaboration with the Institute of Management of Scuola Superiore de Sant'Anna, was very pleased to launch the 'Rethinking Myasthenia Gravis' project on the occasion of EBC's Rare Disease Day event, held on February 20th in Brussels. Rethinking Myasthenia Gravis (MG) is a research-driven project that will offer policy [...]
As a first glimpse into the second phase of the “Rethinking Schizophrenia’ project, this brief policy report provides an introduction to the ‘Optimising the Schizophrenia Care Pathway’ project, as well as the resulting policy recommendations. This report, a collaborative effort from the European Brain Council (EBC) and the European Psychiatric Association (EPA), builds directly [...]
The European Brain Council is pleased to endorse "Science Matters!", a statement from FENS – the Federation of European Neuroscience Societies & Allies. Science drives discoveries that expand knowledge and understanding of ourselves, the world, and future possibilities, based on rigorous, evidence-based research. Together with many others, FENS – the Federation of European Neuroscience [...]
Reducing alcohol consumption improves both individual and societal health – this is the key finding of a new research review presented on Wednesday 5 March 2025 during the launch event "Health & Social Benefits from Reduced Alcohol Consumption: When Less is More", hosted by MEP Jonas Sjöstedt. Organised by IOGT-NTO, in collaboration with EBC [...]
On 24 February 2025, the World Health Organization (WHO) released its 2024 European Health Report, marking the end of the European Programme of Work 2020-2025 and reflecting on key achievements and major public health challenges the European region is facing. It is structured into several sections, covering topics such as non-communicable diseases and mental [...]
